KELLY GORDON: Open Payments
NPI 1194349019 · WEEKI WACHEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 46 payments from 12 companies in 2025. Trend: 2023 $199 · 2024 $1,287 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $344 |
| Axsome Therapeutics, Inc. | 9 | $289 |
| E.R. Squibb & Sons, L.L.C. | 3 | $243 |
| Teva Pharmaceuticals USA, Inc. | 3 | $168 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| ABBVIE INC. | 3 | $64 |
| Supernus Pharmaceuticals, Inc. | 3 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Corium, LLC | 4 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
Products named: CAPLYTA, Auvelity, COBENFY, AUSTEDO XR, REXULTI, VRAYLAR, Qelbree, Jornay PM.
Industry payments across FL — which companies pay providers there.
